True Private Wealth Advisors Pfizer Inc Transaction History

True Private Wealth Advisors

$799 Million
Q3 2024

A detailed history of True Private Wealth Advisors transactions in Pfizer Inc stock. As of the latest transaction made, True Private Wealth Advisors holds 61,558 shares of PFE stock, worth $1.65 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

61,558

Previous 75,798 18.79%

Holding current value

$1.65 Million

Previous $2.12 Million 15.99%

% of portfolio

0.22%

Previous 0.25%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$27.7 - $31.39 $394,448 - $446,993	-14,240 Reduced 18.79%	61,558 $1.78 Million
Q2 2024 Jul 16, 2024	BUY	$25.26 - $29.6 $215,973 - $253,080	8,550 Added 12.71%	75,798 $2.12 Million
Q1 2024 Apr 25, 2024	SELL	$25.89 - $29.73 $49,527 - $56,873	-1,913 Reduced 2.77%	67,248 $1.87 Million
Q4 2023 Jan 30, 2024	SELL	$26.13 - $33.94 $2.38 Million - $3.09 Million	-90,997 Reduced 56.82%	69,161 $1.99 Million
Q3 2023 Nov 13, 2023	BUY	$32.09 - $37.51 $654,411 - $764,941	20,393 Added 14.59%	160,158 $5.31 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $104,206 - $120,564	2,885 Added 2.11%	139,765 $5.13 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $379,995 - $494,698	9,647 Added 7.58%	136,880 $5.58 Million
Q4 2022 Feb 14, 2023	SELL	$41.75 - $54.5 $84,961 - $110,907	-2,035 Reduced 1.57%	127,233 $6.52 Million
Q3 2022 Nov 04, 2022	BUY	$43.76 - $53.42 $254,420 - $310,583	5,814 Added 4.71%	129,268 $5.66 Million
Q2 2022 Jul 28, 2022	BUY	$46.53 - $55.17 $104,459 - $123,856	2,245 Added 1.85%	123,454 $6.47 Million
Q1 2022 May 09, 2022	SELL	$45.75 - $56.69 $221,338 - $274,266	-4,838 Reduced 3.84%	121,209 $6.02 Million
Q4 2021 Feb 11, 2022	SELL	$41.32 - $61.25 $286,967 - $425,381	-6,945 Reduced 5.22%	126,047 $7.44 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $138,042 - $177,327	3,517 Added 2.72%	132,992 $5.72 Million
Q2 2021 Aug 10, 2021	BUY	$35.91 - $40.68 $195,817 - $221,828	5,453 Added 4.4%	129,475 $5.07 Million
Q1 2021 May 12, 2021	BUY	$33.49 - $37.77 $712,365 - $803,405	21,271 Added 20.7%	124,022 $4.49 Million
Q4 2020 Jan 11, 2021	BUY	$33.47 - $42.56 $79,491 - $101,080	2,375 Added 2.37%	102,751 $3.78 Million
Q3 2020 Oct 09, 2020	BUY	$31.75 - $37.25 $181,038 - $212,399	5,702 Added 6.02%	100,376 $3.68 Million
Q2 2020 Jul 07, 2020	BUY	$30.12 - $36.54 $80,390 - $97,525	2,669 Added 2.9%	94,674 $3.1 Million
Q1 2020 Apr 20, 2020	BUY	$27.03 - $38.62 $1.25 Million - $1.78 Million	46,072 Added 100.3%	92,005 $3 Million
Q4 2019 Jan 27, 2020	BUY	$32.92 - $37.36 $1,942 - $2,204	59 Added 0.13%	45,933 $1.8 Million
Q3 2019 Oct 09, 2019	BUY	$32.49 - $42.13 $70,698 - $91,674	2,176 Added 4.98%	45,874 $1.65 Million
Q2 2019 Aug 01, 2019	BUY	$36.98 - $41.52 $114,564 - $128,628	3,098 Added 7.63%	43,698 $1.89 Million
Q1 2019 Apr 25, 2019	SELL	$37.5 - $41.2 $515,400 - $566,252	-13,744 Reduced 25.29%	40,600 $1.72 Million
Q4 2018 Jan 14, 2019	BUY	$38.47 - $43.86 $177,923 - $202,852	4,625 Added 9.3%	54,344 $2.37 Million
Q3 2018 Oct 18, 2018	SELL	$34.47 - $41.81 $359,384 - $435,911	-10,426 Reduced 17.33%	49,719 $0
Q2 2018 Jul 13, 2018	BUY	$32.98 - $35.16 $181,258 - $193,239	5,496 Added 10.06%	60,145 $2.18 Million
Q1 2018 Apr 25, 2018	BUY	$31.91 - $37.02 $89,156 - $103,433	2,794 Added 5.39%	54,649 $1.94 Million
Q4 2017 Jan 19, 2018	BUY	$33.26 - $35.29 $401,381 - $425,879	12,068 Added 30.33%	51,855 $1.88 Million
Q3 2017 Oct 27, 2017	SELL	$31.0 - $34.15 $41,664 - $45,897	-1,344 Reduced 3.27%	39,787 $1.42 Million
Q2 2017 Aug 07, 2017	BUY	N/A	41,131	41,131 $1.38 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of True Private Wealth Advisors, based on Form 13F filings with the SEC.

News

Stay updated on True Private Wealth Advisors with notifications on news.

Account

True Private Wealth Advisors Pfizer Inc Transaction History